BAX vs BDX vs RVP Stock Comparison

Baxter International, Becton Dickinson and Retractable Technologies Prices as of Oct 23, 2026 Peers: Industry group
BAX Baxter International Inc
$25.31 +7.7% 1M +10.1% 1Y
Market cap
$13.08B
P/E
–
Revenue (TTM)
$5.55B
Div. yield
0.01%
Medical Supplies Healthcare
2 wins
BDX Becton Dickinson & Co
$198.85 +8.8% 1M +6.6% 1Y
Market cap
$53.87B
P/E
57.2x
Revenue (TTM)
$23.25B
Div. yield
–
Medical Supplies Healthcare
7 wins

Head to Head

10 decided of 12

Becton Dickinson leads on 7 of the 12 questions below (Becton Dickinson 7, Baxter International 2, Retractable Technologies 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBAXBDXRVPLeader
Larger companyMarket capitalisation $13.08B $53.87B $17.36M BDX
Cheaper on earningsLower P/E, profitable companies only -12.3x 57.2x -4.8x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 12.8x 15.3x — BAX
Faster revenue growthRevenue growth, trailing twelve months -49.1% +17.4% -11.2% BDX
More profitableNet margin, trailing twelve months -19.2% 4.0% -10.6% BDX
Better return on capitalReturn on invested capital 3.4% 5.3% -31.4% BDX
Less leveragedLower net debt / EBITDA 4.8x 3.2x 2.6x RVP
Higher dividend yieldTrailing dividend yield 0.01% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +10.1% +6.6% -39.0% BAX
Better 5-year returnAnnualised price return, 5 years -21.0%/yr -4.3%/yr -43.6%/yr BDX
Less volatileAnnualised volatility, 1 year 44.3% 31.8% 40.4% BDX
Higher overall scoreMean of the five percentile scores vs peers 44/100 67/100 52/100 BDX

Percentile Scorecard

BAXBDXRVP

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBAXBDXRVP
Valuation 83 #40 of 228 89 #25 of 228 74 #61 of 228
Growth 18 #182 of 222 48 #117 of 222 33 #149 of 222
Profitability 72 #59 of 210 78 #48 of 210 39 #129 of 210
Financial Health 18 #197 of 241 26 #178 of 241 65 #86 of 241
Shareholder Returns 27 #101 of 138 95 #8 of 138 –
Overall 44 67 52
  • BAX ranked among 248 companies in Medical Devices and Diagnostics
  • BDX ranked among 248 companies in Medical Devices and Diagnostics
  • RVP ranked among 248 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBAXBDXRVPSPY
1 month +7.7%+8.8%-17.1% -1.0%
3 months +13.0%+27.2%-14.7% +2.9%
6 months +39.4%+30.7%-10.6% +6.4%
Year to date +32.4%+2.5%-24.9% +11.4%
1 year +10.1%+6.6%-39.0% +13.1%
3 years -22.3%-23.3%-49.6% +79.4%
3 years, per year -8.1%-8.5%-20.4% +21.5%
5 years -69.2%-19.5%-94.3% +67.7%
5 years, per year -21.0%-4.3%-43.6% +10.9%
10 years -47.5%+15.4%-77.7% +255.2%
10 years, per year -6.2%+1.4%-13.9% +13.5%

Risk

MeasureBAXBDXRVPSPY
Volatility, 1Y 44.3%31.8%40.4% 12.7%
Downside volatility, 1Y 48.4%33.1%44.7% 12.7%
Beta vs S&P 500, 1Y 1.160.340.14 1.00
Return / volatility, 1Y 0.230.21-0.97 1.03
Max drawdown, 5Y -82.3%-50.4%-94.3% -25.4%
From 52-week high -10.7%-5.3%-39.0% -2.5%
52-week high $28.35$210.02$0.95 $779.14
52-week low $15.80$140.71$0.58 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBAXBDXRVP
P/E now vs peer median -12.3xmedian 30.7x 58.1xmedian 30.7x -4.8xmedian 30.7x
P/S now vs peer median 2.4xmedian 3.0x 2.3xmedian 3.0x 0.5xmedian 3.0x
EV/EBITDA now vs peer median 13.5xmedian 17.7x 14.1xmedian 17.7x 1.5xmedian 17.7x
P/FCF now vs peer median 15.6xmedian 23.7x 16.9xmedian 23.7x -3.4xmedian 23.7x
P/B now vs peer median 2.1xmedian 2.4x 2.2xmedian 2.4x 0.2xmedian 2.4x
PEG now vs peer median -0.43median 0.96 -3.98median 0.96 0.22median 0.96

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBAXBDXRVP
Revenue $5.55B $23.25B $33.90M
Gross profit $3.78B $10.91B -$491.51K
Operating income $532.00M $2.48B -$22.68M
Net income -$1.06B $941.00M -$3.37M
Free cash flow $839.00M $3.20B -$5.11M
R&D $542.00M $1.37B $682.03K
EPS (diluted) $-2.05 $3.42 $-0.12
Cash & equivalents $2.15B $708.00M $2.64M
Total debt $9.46B $72.81B $3.40M
Shares (diluted) 518.00M 275.16M 29.94M
Enterprise value $5.21B $51.02B -$129.04M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBAXBDXRVP
P/E -12.3x 58.1x -4.8x
P/FCF 15.6x 16.9x -3.4x
P/Operating cash flow 9.7x 13.7x -3.5x
P/S 2.4x 2.3x 0.5x
P/B 2.1x 2.2x 0.2x
P/Tangible book 6.1x 2.3x 0.2x
EV/EBITDA 13.5x 14.1x 1.5x
EV/EBIT 38.3x 28.3x 1.0x
EV/Revenue 3.7x 3.0x -0.6x
EV/FCF 24.3x 21.9x 4.3x
EV/Operating cash flow 15.2x 17.8x 4.4x
PEG (3Y EPS CAGR) -0.43 -3.98 0.22

Growth

14 metrics
MetricBAXBDXRVP
Revenue growth (1Y) -49.1% 17.4% -11.2%
Revenue CAGR (3Y) -23.5% 6.9% -14.7%
Gross profit growth (1Y) -1.8% 23.7% 81.2%
Gross profit CAGR (3Y) -5.2% 8.5% -26.8%
Operating income growth (1Y) -50.8% 13.0% -2.3%
Operating income CAGR (3Y) 29.5% 3.3% -11.7%
Net income growth (1Y) -604.0% -40.6% 61.4%
Net income CAGR (3Y) 28.0% -17.3% -23.9%
EPS growth (1Y) -580.5% -38.0% 59.8%
EPS CAGR (3Y) 28.6% -14.6% -21.9%
Operating cash flow growth (1Y) 56.3% 43.5% 58.8%
Operating cash flow CAGR (3Y) -4.8% 14.5% -16.8%
Free cash flow growth (1Y) 153.5% 54.2% 62.3%
Free cash flow CAGR (3Y) -9.5% 22.5% 20.0%

Profitability

14 metrics
MetricBAXBDXRVP
Gross margin 68.1% 46.9% -1.4%
EBITDA margin 27.3% 21.4% -43.9%
Operating margin 9.6% 10.7% -66.9%
Pretax margin 5.1% 8.4% -9.9%
Net margin -19.2% 4.0% -10.6%
FCF margin 15.1% 13.8% -15.1%
Operating cash flow margin 24.2% 17.0% -14.6%
Return on equity -17.4% 3.9% -4.7%
Return on assets -5.4% 1.9% -2.4%
Return on invested capital 3.4% 5.3% -31.4%
Return on capital employed 3.3% 6.0% -18.0%
Asset turnover 0.3x 0.5x 0.2x
Cash conversion (OCF / net income) -1.3x 4.2x 1.5x
Stock comp / revenue 2.1% 1.2% –

Financial Health

11 metrics
MetricBAXBDXRVP
Debt / assets 47.8% 33.1% 0.5%
Debt / equity 1.5x 0.7x 0.0x
Net debt / EBITDA 4.8x 3.2x 2.6x
Debt / FCF 11.3x 5.2x -0.1x
Liabilities / assets 68.6% 51.9% 48.6%
Equity / assets 31.4% 48.1% 51.4%
Interest coverage – 4.2x -278.8x
Current ratio 1.9x 0.9x 4.9x
Quick ratio 1.1x 0.3x 3.7x
Cash ratio 0.6x 0.1x 3.0x
Altman Z-score 2.13 2.31 0.43

Shareholder Returns

7 metrics
MetricBAXBDXRVP
Dividend yield 0.2% 2.1% –
Net buyback yield -0.2% 4.6% –
Shareholder yield 0.0% 6.7% –
Payout ratio (earnings) -17.3% – –
Payout ratio (FCF) 21.9% – –
Dividend growth (1Y) -60.8% – –
Dividend CAGR (3Y) -32.0% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBAXBDXRVP
Forward P/E 12.8xFY2026 15.3xFY2026 –
EPS, next fiscal year $1.98FY2026 $12.99FY2026 –
EPS growth, next FY -10.4%FY2026 +14.8%FY2026 –
EPS growth, the year after -3.5% -3.0% –
Revenue, next fiscal year $11.05BFY2026 $18.11BFY2026 –
Revenue growth, next FY -1.7%FY2026 -17.1%FY2026 –
Revenue growth, the year after +11.7% +11.7% –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBAXBDXRVP
Held by institutions 100.0% 96.1% 8.8%
Institutions holding 690 1,442 32
Change in shares held, QoQ +5.2% +0.6% +5.9%
Institutions buying 359 688 10
Institutions selling 193 543 4
Buyers to sellers 1.86 1.27 2.50

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BAXBDXRVP
BAX 1.00 0.39 0.06
BDX 0.39 1.00 0.02
RVP 0.06 0.02 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BAX, BDX and RVP?

Becton Dickinson (BDX) is the largest by market capitalisation: Baxter International (BAX) $13.08B, Becton Dickinson (BDX) $53.87B, Retractable Technologies (RVP) $17.36M.

Which company is growing faster?

Becton Dickinson (BDX) grew revenue fastest over the trailing twelve months: Baxter International (BAX) -49.1%, Becton Dickinson (BDX) +17.4%, Retractable Technologies (RVP) -11.2%.

Which company is more profitable?

Becton Dickinson (BDX) has the highest net margin (Baxter International (BAX) -19.2%, Becton Dickinson (BDX) 4.0%, Retractable Technologies (RVP) -10.6%). On return on invested capital, Becton Dickinson (BDX) leads (Baxter International (BAX) 3.4%, Becton Dickinson (BDX) 5.3%, Retractable Technologies (RVP) -31.4%).

Which stock has performed better?

Over the past year Baxter International (BAX) returned the most: Baxter International (BAX) +10.1%, Becton Dickinson (BDX) +6.6%, Retractable Technologies (RVP) -39.0%. Over five years, Becton Dickinson (BDX) compounded fastest (Baxter International (BAX) -21.0%/yr, Becton Dickinson (BDX) -4.3%/yr, Retractable Technologies (RVP) -43.6%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Baxter International (BAX) 0.01%, Becton Dickinson (BDX) 0.00%, Retractable Technologies (RVP) 0.00%. Becton Dickinson (BDX) and Retractable Technologies (RVP) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Becton Dickinson (BDX) has been the steadiest (Baxter International (BAX) 44.3%, Becton Dickinson (BDX) 31.8%, Retractable Technologies (RVP) 40.4%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BAX, BDX and RVP?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Becton Dickinson (BDX) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.